AngioDynamics, Inc. (ANGO) Balance Sheet

NASDAQ: ANGOAssets, liabilities, debt and equity over 10 years.

ANGO balance sheet, FY2026

May 31, 2026 · U.S. dollars

$267.2M assets = $96.3M liabilities + $170.8M equity

What it owns$267.2MCash & ST investments: $53.9M (20.2%)Cash & ST investments$53.9M · 20%Receivables: $48.3M (18.1%)Receivables$48.3M · 18%Inventory: $52.4M (19.6%)Inventory$52.4M · 20%Other current: $8.8M (3.3%)PP&E: $27.1M (10.1%)PP&E $27.1MGoodwill & intangibles: $67.2M (25.2%)Goodwill & intangibles$67.2M · 25%Other non-current: $9.5M (3.5%)=How it is financed$267.2MCurrent liabilities: $74.7M (28.0%)Current liabilities$74.7M · 28%Other LT liabilities: $21.6M (8.1%)$21.6MShareholders’ equity: $170.8M (63.9%)Shareholders’ equity$170.8M · 64%

Both columns are drawn to the same scale: what ANGO owns equals what it owes plus shareholders’ equity. Hover a block for its value.

ANGO financial health

Current ratio2.19
Comfortable · current assets cover current liabilities 2.19×
Equity / assets63.9%
Equity-funded · of assets funded by shareholders
Goodwill & intangibles25.2%
Acquisition-heavy · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

ANGO balance sheet trends, FY2017–FY2026

AngioDynamics, Inc. balance sheet trends
MetricTrendThenLatestChange
Total assets$708.0MFY2017$267.2MFY2026−10.3%/yr
Total liabilities$190.9MFY2017$96.3MFY2026−7.3%/yr
Shareholders’ equity$517.0MFY2017$170.8MFY2026−11.6%/yr
Cash & short-term investments$48.8MFY2017$53.9MFY2026+1.1%/yr
Total debt$105.9MFY2017$10.1MFY2025−25.4%/yr
Net cash (debt)−$57.2MFY2017$45.7MFY2025+$102.9M
Working capital$84.4MFY2017$88.7MFY2026+$4.3M
Book value per share$13.99FY2017$4.11FY2026−12.7%/yr
Current ratio2.21FY20172.19FY2026−0.03
Debt / equity0.20FY20170.06FY2025−0.15
Shares outstanding37.0MFY201741.5MFY2026+1.3%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

ANGO assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

ANGO liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

ANGO debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

ANGO balance sheet

AngioDynamics, Inc. annual balance sheet
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Assets
Cash & short-term investments$53.9M$55.9M$76.1M$44.6M$28.8M$48.2M$54.4M$227.6M$75.4M$48.8M
Cash & equivalents$53.9M$55.9M$76.1M$44.6M$28.8M$48.2M$54.4M$227.6M$74.1M$47.5M
Short-term investments——————$689,000$0$1.3M$1.2M
Receivables$48.3M$43.1M$50.0M$52.8M$56.5M$35.4M$34.2M$43.6M$39.4M$46.4M
Inventory$52.4M$62.0M$60.6M$55.3M$51.4M$48.6M$59.9M$40.1M$39.3M$54.5M
Other current assets$8.8M$7.3M$6.6M$10.8M$6.6M$8.7M$4.4M$4.0M$13.9M$4.3M
Total current assets$163.4M$168.3M$193.3M$163.5M$143.3M$140.9M$152.9M$315.3M$168.0M$153.9M
Property, plant & equipment (net)$27.1M$32.3M$35.7M$44.4M$45.0M$37.1M$28.3M$24.3M$25.7M$45.2M
Goodwill & intangible assets$67.2M$69.1M$77.4M$270.4M$353.4M$370.3M$398.7M$493.1M$491.6M$506.9M
Long-term investments$0$0$0$0$0$0$0$0$0$0
Other non-current assets$9.5M$10.4M$11.4M$54.3M$11.0M$13.2M$15.6M$3.8M$20.2M$1.9M
Total assets$267.2M$280.1M$317.7M$532.6M$552.8M$561.4M$595.5M$836.4M$705.5M$708.0M
Liabilities
Accounts payable$31.5M$33.3M$37.8M$40.4M$28.0M$19.6M$19.1M$22.8M$15.8M$18.1M
Short-term debt—$2.2M$4.7M$14.8M$8.8M$2.4M$836,000$12.1M$7.1M$14.6M
Deferred revenue———−$14.8M$16.0M−$2.4M$29.5M—$32.3M$27.2M
Total current liabilities$74.7M$76.2M$91.2M$83.8M$74.3M$57.6M$51.5M$73.3M$57.3M$69.5M
Long-term debt$0$0$0$49.8M$25.0M$20.0M$40.0M$124.4M$86.6M$91.3M
Other long-term liabilities$21.6M$21.0M$20.9M$20.7M$28.9M$44.4M$48.1M$23.9M$19.0M$30.1M
Total liabilities$96.3M$97.2M$112.1M$154.3M$128.3M$122.0M$139.6M$221.6M$162.9M$190.9M
Shareholders' equity
Common stock & paid-in capital$387,000$385,000$385,000$382,000$380,000$377,000$374,000$372,000$370,000$367,000
Retained earnings (deficit)−$465.9M−$429.2M−$395.2M−$210.9M−$158.4M−$131.9M−$100.3M$66.5M$5.1M−$11.0M
Treasury stock———−$5.7M−$5.7M−$5.7M−$5.7M−$5.7M−$5.7M−$5.7M
Accumulated other comprehensive income$7.7M−$2.0M−$4.4M−$4.7M$1.4M$3.2M−$1.3M−$1.4M−$952,000−$1.3M
Minority interest————————$0$0
Total shareholders' equity$170.8M$183.0M$205.6M$378.3M$424.5M$439.5M$455.9M$614.8M$542.6M$517.0M
Key figures
Total debt—$10.1M$4.7M$64.6M$33.8M$22.4M$40.8M$136.5M$93.7M$105.9M
Net cash (debt)—$45.7M$71.3M−$20.0M−$5.0M$25.7M$13.6M$91.1M−$18.3M−$57.2M
Working capital$88.7M$92.1M$102.1M$79.7M$69.0M$83.3M$101.4M$242.0M$110.7M$84.4M
Tangible book value$103.6M$113.9M$128.2M$107.9M$71.1M$69.2M$57.2M$121.8M$51.0M$10.1M
Book value per share$4.11$4.46$5.12$9.58$10.88$11.46$12.01$16.40$14.45$13.99
Shares outstanding41.5M41.0M40.2M39.5M39.0M38.3M38.0M37.5M37.5M37.0M
Current ratio2.192.212.121.951.932.452.974.302.932.21
Quick ratio1.371.301.381.161.151.451.723.702.001.37
Debt / equity—0.060.020.170.080.050.090.220.170.20
Equity / assets63.9%65.3%64.7%71.0%76.8%78.3%76.6%73.5%76.9%73.0%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed July 14, 2026); data from EODHD.

ANGO financial position

At the end of fiscal 2026 (May 31, 2026), AngioDynamics had total assets of $267.2 million (down 4.6% from a year earlier), total liabilities of $96.3 million and shareholders' equity of $170.8 million. Its current ratio was 2.19. In the latest quarter (ended August 31, 2026) total assets were $241.9 million and equity $164.0 million.

Related: ANGO income statement, ANGO cash flow statement, ANGO key metrics. See the ANGO stock overview for the latest quote and news.

ANGO balance sheet FAQ

What are AngioDynamics's total assets?

AngioDynamics reported total assets of $267.2 million at the end of fiscal 2026 (May 31, 2026), compared with $280.1 million a year earlier.

How much cash does AngioDynamics have?

AngioDynamics held $53.9 million in cash and short-term investments at the end of fiscal 2026.

What is AngioDynamics's book value?

AngioDynamics's shareholders' equity (book value) was $170.8 million at the end of fiscal 2026, or $4.11 per share.

What is AngioDynamics's current ratio?

AngioDynamics had current assets of $163.4 million and current liabilities of $74.7 million, a current ratio of 2.19 (it can cover its short-term obligations).

How much goodwill does AngioDynamics have?

AngioDynamics carried $67.2 million of goodwill and intangible assets, 25.2% of total assets, at the end of fiscal 2026.

Medical Instruments & Supplies: balance sheet